Largest-ever COVID vaccine study links shot to small increase in heart, brain conditions

Archived from the original Sajha.com — preserved as posted, replies can no longer be added here.
Start a New Discussion
Archived Post

By&nbsp;Melissa Rudy Published&nbsp;February 20, 2024 9:39AM Health Texas AG sues Pfizer over COVID-19 vaccine Texas Attorney General Ken Paxton is suing Pfizer, alleging that the pharmaceutical giant lied about the effectiveness of its COVID-19 vaccine. LiveNOW's Carel Lajara spoke about the lawsuit with Infectious disease expert Dr. Peter Chin-Hong. The largest&nbsp;COVID vaccine&nbsp;study to date has identified some risks associated with the shot. Researchers from the Global Vaccine Data Network (GVDN) in New Zealand analyzed 99 million people who received COVID vaccinations across eight countries. They monitored for increases in 13 different medical conditions in the period after people received a&nbsp;COVID vaccine. The study, which was published in the journal Vaccine last week, found that the vaccine was linked to a slight increase in neurological, blood and heart-related medical conditions, according to a press release from GVDN. LONG COVID IS HIGHEST IN THESE STATES, SAYS NEW CDC REPORT People who received certain types of mRNA vaccines were found to have a higher risk of myocarditis, which is inflammation of the heart muscle. Some viral-vector vaccines were linked to a higher risk of blood clots in the brain, as well as an increased likelihood of Guillain-Barre syndrome, a neurological disorder in which the immune system attacks the nerves. Other potential risks included inflammation of part of the spinal cord after viral vector vaccines, and inflammation and swelling in the&nbsp;brain and spinal cord&nbsp;after viral vector and mRNA vaccines, the press release stated. SHOULD THE CDC DROP ITS 5-DAY COVID ISOLATION GUIDELINES? DOCTORS WEIGH IN "The size of the population in this study increased the possibility of identifying rare potential vaccine safety signals," lead author Kristýna Faksová of the Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark, said in the release. "Single sites or regions are unlikely to have a large enough population to detect very rare signals." File: A pharmacist, prepares to give a COVID-19 vaccine in Cypress, Texas, Sept. 20, 2023. (Melissa Phillip/Houston Chronicle via Getty Images) Doctors react to the findings Dr. Marc Siegel, clinical professor of medicine at&nbsp;NYU Langone Medical Center&nbsp;and a Fox News medical contributor, was not involved in the research but commented on the findings. "The massive study and review of the data reveals some rare association of the MRNA vaccines and myocarditis, especially after the second shot, as well as an association between the Oxford Astra Zeneca adenovirus vector vaccines and Guillain Barre syndrome," he told Fox News Digital. "But these risks are rare," he added, "and other studies show that the vaccine decreases the risk of myocarditis from COVID itself dramatically." COVID VARIANT JN.1 NO MORE SEVERE THAN PREVIOUS STRAINS, CDC DATA SHOWS Siegel noted that all vaccines have side effects. "It always comes down to a risk/benefit analysis of what you are more afraid of — the vaccine's side effects or the virus itself, which can have long-term side effects in terms of brain fog, fatigue, cough and also&nbsp;heart issues," he said. "Denying or exaggerating a vaccine's side effects is not good science — nor is underestimating the risks of the virus, especially in high-risk groups," Siegel added. "It comes down to a risk/benefit analysis of what you are more afraid of — the vaccine's side effects or the virus itself." The key is for doctors and their patients to carefully weigh the risks and benefits, the doctor emphasized. "This study does not really change anything; it just provides much further evidence of what we already know," he said. <lframe id="player-7651bce4-d98f-4

wakeyour_mind · Feb 21, 2024 2:54 PM · 14 views

Replies
No replies yet.

This conversation is preserved exactly as it was on the original Sajha.com and can't accept new replies.

Start a New Discussion